The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Progenitor Cell Product-Global Market Insights and Sales Trends 2025

Progenitor Cell Product-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1837697

No of Pages : 101

Synopsis
Progenitor Cell, also called stem cell, a biological cell that can differentiate into a specific cell type.
The global Progenitor Cell Product market size is expected to reach US$ 23180 million by 2029, growing at a CAGR of 9.7% from 2023 to 2029. The market is mainly driven by the significant applications of Progenitor Cell Product in various end use industries. The expanding demands from the Medical care, Hospital and Laboratory,, are propelling Progenitor Cell Product market. Pancreatic progenitor cells, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cardiac Progenitor Cells segment is estimated at % CAGR for the next seven-year period.
Rising development of precision medicine, increasing number of cell therapy production facilities, and increasing number of clinical trials are expected to be the major driving factors for the market. Recent advances in stem cell therapy and tissue engineering have the potential to draw attention to the treatment of a variety of diseases. Moreover, rising demand for stem cell banks and rising research activities related to stem cell production, storage, and characterization are also expected to drive market revenue growth.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Progenitor Cell Product, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Progenitor Cell Product market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Progenitor Cell Product market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Progenitor Cell Product sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Progenitor Cell Product covered in this report include NeuroNova AB, StemCells, ReNeuron Limited, Asterias Biotherapeutics, Thermo Fisher Scientific, STEMCELL Technologies, Axol Bio, R&D Systems and Lonza, etc.
The global Progenitor Cell Product market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
NeuroNova AB
StemCells
ReNeuron Limited
Asterias Biotherapeutics
Thermo Fisher Scientific
STEMCELL Technologies
Axol Bio
R&D Systems
Lonza
ATCC
Irvine Scientific
CDI
Global Progenitor Cell Product market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Progenitor Cell Product market, Segment by Type:
Pancreatic progenitor cells
Cardiac Progenitor Cells
Intermediate progenitor cells
Neural progenitor cells (NPCs)
Endothelial progenitor cells (EPC)
Others
Global Progenitor Cell Product market, by Application
Medical care
Hospital
Laboratory
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Progenitor Cell Product companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Progenitor Cell Product
1.1 Progenitor Cell Product Market Overview
1.1.1 Progenitor Cell Product Product Scope
1.1.2 Progenitor Cell Product Market Status and Outlook
1.2 Global Progenitor Cell Product Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Progenitor Cell Product Market Size by Region (2018-2029)
1.4 Global Progenitor Cell Product Historic Market Size by Region (2018-2023)
1.5 Global Progenitor Cell Product Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Progenitor Cell Product Market Size (2018-2029)
1.6.1 North America Progenitor Cell Product Market Size (2018-2029)
1.6.2 Europe Progenitor Cell Product Market Size (2018-2029)
1.6.3 Asia-Pacific Progenitor Cell Product Market Size (2018-2029)
1.6.4 Latin America Progenitor Cell Product Market Size (2018-2029)
1.6.5 Middle East & Africa Progenitor Cell Product Market Size (2018-2029)
2 Progenitor Cell Product Market by Type
2.1 Introduction
2.1.1 Pancreatic progenitor cells
2.1.2 Cardiac Progenitor Cells
2.1.3 Intermediate progenitor cells
2.1.4 Neural progenitor cells (NPCs)
2.1.5 Endothelial progenitor cells (EPC)
2.1.6 Others
2.2 Global Progenitor Cell Product Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Progenitor Cell Product Historic Market Size by Type (2018-2023)
2.2.2 Global Progenitor Cell Product Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Progenitor Cell Product Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Progenitor Cell Product Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Progenitor Cell Product Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Progenitor Cell Product Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Progenitor Cell Product Revenue Breakdown by Type (2018-2029)
3 Progenitor Cell Product Market Overview by Application
3.1 Introduction
3.1.1 Medical care
3.1.2 Hospital
3.1.3 Laboratory
3.2 Global Progenitor Cell Product Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Progenitor Cell Product Historic Market Size by Application (2018-2023)
3.2.2 Global Progenitor Cell Product Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Progenitor Cell Product Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Progenitor Cell Product Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Progenitor Cell Product Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Progenitor Cell Product Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Progenitor Cell Product Revenue Breakdown by Application (2018-2029)
4 Progenitor Cell Product Competition Analysis by Players
4.1 Global Progenitor Cell Product Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Progenitor Cell Product as of 2022)
4.3 Date of Key Players Enter into Progenitor Cell Product Market
4.4 Global Top Players Progenitor Cell Product Headquarters and Area Served
4.5 Key Players Progenitor Cell Product Product Solution and Service
4.6 Competitive Status
4.6.1 Progenitor Cell Product Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 NeuroNova AB
5.1.1 NeuroNova AB Profile
5.1.2 NeuroNova AB Main Business
5.1.3 NeuroNova AB Progenitor Cell Product Products, Services and Solutions
5.1.4 NeuroNova AB Progenitor Cell Product Revenue (US$ Million) & (2018-2023)
5.1.5 NeuroNova AB Recent Developments
5.2 StemCells
5.2.1 StemCells Profile
5.2.2 StemCells Main Business
5.2.3 StemCells Progenitor Cell Product Products, Services and Solutions
5.2.4 StemCells Progenitor Cell Product Revenue (US$ Million) & (2018-2023)
5.2.5 StemCells Recent Developments
5.3 ReNeuron Limited
5.3.1 ReNeuron Limited Profile
5.3.2 ReNeuron Limited Main Business
5.3.3 ReNeuron Limited Progenitor Cell Product Products, Services and Solutions
5.3.4 ReNeuron Limited Progenitor Cell Product Revenue (US$ Million) & (2018-2023)
5.3.5 Asterias Biotherapeutics Recent Developments
5.4 Asterias Biotherapeutics
5.4.1 Asterias Biotherapeutics Profile
5.4.2 Asterias Biotherapeutics Main Business
5.4.3 Asterias Biotherapeutics Progenitor Cell Product Products, Services and Solutions
5.4.4 Asterias Biotherapeutics Progenitor Cell Product Revenue (US$ Million) & (2018-2023)
5.4.5 Asterias Biotherapeutics Recent Developments
5.5 Thermo Fisher Scientific
5.5.1 Thermo Fisher Scientific Profile
5.5.2 Thermo Fisher Scientific Main Business
5.5.3 Thermo Fisher Scientific Progenitor Cell Product Products, Services and Solutions
5.5.4 Thermo Fisher Scientific Progenitor Cell Product Revenue (US$ Million) & (2018-2023)
5.5.5 Thermo Fisher Scientific Recent Developments
5.6 STEMCELL Technologies
5.6.1 STEMCELL Technologies Profile
5.6.2 STEMCELL Technologies Main Business
5.6.3 STEMCELL Technologies Progenitor Cell Product Products, Services and Solutions
5.6.4 STEMCELL Technologies Progenitor Cell Product Revenue (US$ Million) & (2018-2023)
5.6.5 STEMCELL Technologies Recent Developments
5.7 Axol Bio
5.7.1 Axol Bio Profile
5.7.2 Axol Bio Main Business
5.7.3 Axol Bio Progenitor Cell Product Products, Services and Solutions
5.7.4 Axol Bio Progenitor Cell Product Revenue (US$ Million) & (2018-2023)
5.7.5 Axol Bio Recent Developments
5.8 R&D Systems
5.8.1 R&D Systems Profile
5.8.2 R&D Systems Main Business
5.8.3 R&D Systems Progenitor Cell Product Products, Services and Solutions
5.8.4 R&D Systems Progenitor Cell Product Revenue (US$ Million) & (2018-2023)
5.8.5 R&D Systems Recent Developments
5.9 Lonza
5.9.1 Lonza Profile
5.9.2 Lonza Main Business
5.9.3 Lonza Progenitor Cell Product Products, Services and Solutions
5.9.4 Lonza Progenitor Cell Product Revenue (US$ Million) & (2018-2023)
5.9.5 Lonza Recent Developments
5.10 ATCC
5.10.1 ATCC Profile
5.10.2 ATCC Main Business
5.10.3 ATCC Progenitor Cell Product Products, Services and Solutions
5.10.4 ATCC Progenitor Cell Product Revenue (US$ Million) & (2018-2023)
5.10.5 ATCC Recent Developments
5.11 Irvine Scientific
5.11.1 Irvine Scientific Profile
5.11.2 Irvine Scientific Main Business
5.11.3 Irvine Scientific Progenitor Cell Product Products, Services and Solutions
5.11.4 Irvine Scientific Progenitor Cell Product Revenue (US$ Million) & (2018-2023)
5.11.5 Irvine Scientific Recent Developments
5.12 CDI
5.12.1 CDI Profile
5.12.2 CDI Main Business
5.12.3 CDI Progenitor Cell Product Products, Services and Solutions
5.12.4 CDI Progenitor Cell Product Revenue (US$ Million) & (2018-2023)
5.12.5 CDI Recent Developments
6 North America
6.1 North America Progenitor Cell Product Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Progenitor Cell Product Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Progenitor Cell Product Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Progenitor Cell Product Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Progenitor Cell Product Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Progenitor Cell Product Market Dynamics
11.1 Progenitor Cell Product Industry Trends
11.2 Progenitor Cell Product Market Drivers
11.3 Progenitor Cell Product Market Challenges
11.4 Progenitor Cell Product Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’